Nuclear bone scan
Principle
- Bone scintigraphy (technetium-99m-labelled bisphosphonate) detects areas of increased bone turnover - the traditional whole-body screening test for bone metastases, though increasingly supplemented or replaced by PET/MRI in some settings
- Most useful for cancers with a high propensity for osteoblastic (sclerotic) bone metastasis - prostate cancer is the classic and most frequent indication
- The tracer accumulates at sites of active bone remodelling/osteoblastic activity, not the tumour cells themselves - so the scan is a marker of the bone's reactive response to a lesion, not a direct image of tumour tissue
4 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access